From Awareness to Autonomy: Exploring the Knowledge Gap and Acceptability of Self-Injectable DMPA-SC among Women in Central India [PDF]
Indian Journal of Community MedicineBackground: Self-administered subcutaneous depot medroxyprogesterone acetate (DMPA-SC) provides a novel contraceptive modality that can expand access, autonomy, and continuation rates, especially among low-resource populations.
Anita Yadav +5 more
doaj +3 more sources
Influence of Movement Restriction During the COVID-19 Pandemic on Uptake of DMPA-SC and Other Injectable Contraceptive Methods in Nigeria [PDF]
Open Access Journal of ContraceptionAdewole Adebola Adefalu,1 Olufunke Abimbola Bankole,2 Funmilayo Olabode,2 Mojuba Bimbo Afolabi,2 Miranda Atare Buba,2 Victor Dafe,2 Mishael Nnanna Kalu,2 Emily Watkins3 1JSI Research & Training Institute, Inc., Atlanta, GA, USA; 2JSI Research & ...
Adefalu AA +7 more
doaj +4 more sources
How do pro-social tendencies and provider biases affect service delivery? Evidence from the rollout of self-injection of DMPA-SC in Nigeria [PDF]
BMC Women's HealthBackground Inconsistent provision of subcutaneous depot medroxyprogesterone acetate (DMPA-SC) for self-injection (SI) undermines efforts to improve women’s reproductive health agency and access to self-care.
Calvin Chiu +8 more
doaj +3 more sources
Injectable contraceptive continuation and user experiences in Punjab, Pakistan: a non-randomized prospective cohort study protocol [PDF]
BMC Women's HealthBackground Evidence from multiple pilots and post-introduction scale-up initiatives have demonstrated that self-administered subcutaneous depot-medroxyprogesterone acetate (DMPA-SC) has potential to improve contraceptive continuation rates and expand ...
Hannah Tappis +9 more
doaj +3 more sources
Cost-Effectiveness of Self-Injected DMPA-SC Compared With Health-Worker-Injected DMPA-IM in Senegal [PDF]
Contraception: X, 2019 To evaluate the cost-effectiveness of self-injected subcutaneous depot medroxyprogesterone acetate (DMPA-SC) compared to health-worker-administered intramuscular DMPA (DMPA-IM) in Senegal and to assess how including practice or demonstration injections in client self-injection training affects estimates.We developed a decision-tree model with a 12 ...
Mercy Mvundura +2 more
exaly +5 more sources
Trends in Subcutaneous Depot Medroxyprogesterone Acetate (DMPA-SC) Use in Burkina Faso, the Democratic Republic of Congo and Uganda [PDF]
Contraception: X, 2019 Subcutaneous depot medroxyprogesterone acetate (DMPA-SC) is seen as a valuable innovation in family planning, but little is known about trends in DMPA-SC use or characteristics of users. Using data from Burkina Faso, the Democratic Republic of Congo (DRC) and Uganda, we measured trends in DMPA-SC and identified characteristics associated with DMPA-SC ...
Georges Guiella +2 more
exaly +5 more sources
Provision of DMPA-SC for Self-Administration in Different Practice Settings During the COVID-19 Pandemic: Data From Providers Across the United States [PDF]
ContraceptionOBJECTIVES: Depot medroxyprogesterone acetate-subcutaneous (DMPA-SC) can be prescribed through telemedicine and self-administered, but data about availability, particularly during the COVID-19 pandemic, are limited.
Alison B Comfort +2 more
exaly +4 more sources
Determinants of DMPA-SC self-care/self-injectable contraceptive uptake among modern contraceptive users in Burkina Faso: findings from the 2021 demographic and health survey [PDF]
Frontiers in Global Women's HealthIntroductionThis study aimed to identify the determinants that influence the use of DMPA-SC/Sayana Press among women who use modern contraceptive methods in Burkina Faso.MethodsThis study used secondary data obtained from the 2021 Burkina Faso ...
Aristide Romaric Bado
doaj +2 more sources
Designing a Global Monitoring System for Pilot Introduction of a New Contraceptive Technology, Subcutaneous DMPA (DMPA-SC) [PDF]
Evaluation and Program Planning, 2018 In collaboration with ministries of health, PATH and key partners launched the first pilot introductions of subcutaneous depot medroxyprogesterone acetate (DMPA-SC, brand name Sayana® Press) in Burkina Faso, Niger, Senegal, and Uganda from July 2014 through June 2016.
Allen Namagembe
exaly +4 more sources
Enhancing the Introduction and Scale Up of Self-Administered Injectable Contraception (DMPA-SC) in Health Systems (the EASIER Project): Protocol for Embedded Implementation Research [PDF]
JMIR Research Protocols, 2023 BackgroundThe introduction of self-administered injectable contraception presents an opportunity to address the unmet need for family planning.
Colin Baynes +3 more
doaj +2 more sources